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EDITORIAL
While Taylor and Burns (p. 175, this issue)1 eloquently describe
the objectives of the current legislative reform process, the
solutions offered are based largely on existing paradigms.
Despite similar approaches, above-CPI increases in medical
scheme contributions have been the trend.  So-called low-cost
products have also been introduced, but have failed to make
inroads into the expansion of the private health care market.  In
fact, the total insured population has decreased over the last
year,2 meaning that growth in these products is likely to have
been due to migration of existing members of medical schemes,
rather than to attraction of new members.
Suggesting that the private sector has failed poorer and
sicker members is not entirely fair because the major portion of
the costs associated with health care in the private sector is still
borne by the members themselves, despite the tax
subsidisation.  Patients purchase the care they receive using
their own money and by exercising at least some degree of
choice.  However, the authors’ comment that medical schemes
are rapidly becoming unaffordable and therefore increasingly
inaccessible is valid, but this applies to the distribution of the
full-contribution rand and not only the portions spent on the
actual delivery of health care.  In recent years non-health care
costs, which exclude the costs of the increased administrative
burden at the point of service, have been one of the main
contributors to medical inflation.
The notion of a basic health care package is critical in
providing access to care for the greater population and should
be supported by the entire industry.   However, care should be
taken not to throw the proverbial baby out with the bath water
by adopting an all-or-nothing approach. For example, there
may well be room for re-introduction of standard insurance
principles where patients, or consumers, exercise a choice to
purchase more than the basic package.  Similarly, the definition
of affordability should be limited to the cost of the basic health
care package and not include what patients elect to purchase in
addition to such a package.
Serious consideration should be given to redefining the basic
health care package in terms of services, rather than diagnoses.
This will not only start to address the debate around the
inclusion or non-inclusion of certain diagnoses, but also create
a larger focus on preventive as opposed to curative care.  For
obvious reasons the latter is more costly, and lifestyle-related
illnesses in particular have repeatedly been reported as major
cost drivers in the medical scheme environment.  By the same
token HIV/AIDS, for example, should be regarded as a
preventable disease.
It is agreed that alternative reimbursement models should
form part of the solutions to future health care delivery.
However, care should be taken not to create the same pitfalls
encountered after the advent of personal savings accounts and
day-to-day benefit options by inappropriately allocating risks
to parties unable to manage or accept such risks.  On the other
hand, doctors can share in some of the risks associated with
practising their profession, which means that greater
consideration should be given to the development of inclusive
fee structures, as opposed to global fees.  Such fee structures
should also empower doctors to decide on the deployment of
scarce resources and/or new technology and to make their
own clinical decisions without the intervention of clinical risk
management programmes, which in more instances than not
focus on reimbursement decisions rather than actual clinical
interventions.  This will obviate the need for managed care
organisations, rather than the profession, to develop clinical
standards.
It is debatable whether the introduction of prescribed
minimum benefits (PMBs) has in fact decreased the burden on
public sector resources, mainly because in terms of the
Regulations to the Medical Schemes Act 131 of 1998 designated
service providers can be identified as opposed to being
formally contracted by medical schemes.  Hence, a number of
schemes are offering limited benefits with regard to PMBs in
the private sector, whereafter members have to access further
benefits from the public sector, regardless of whether the
required resources are available.  The net effect of this is the
same as the erstwhile dumping of patients, and the future use
of public sector facilities will have to take place on a more
formalised basis.
Finally, participation in the debate by all stakeholders is
unequivocally supported, providing that the playing fields are
levelled and the debate based on mutually agreed-upon
principles, without the coercive fall-back position currently
being employed by elements of the funding industry.  The
changes required are much more fundamental than a mere
transferral of risk from one party to another.  We need to think
afresh and ensure that all the elements of the private sector
remain vibrant and sustainable for the sake of efficient health
care delivery to all, rich and poor, sick and healthy.
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